ISI Modifies PT on Celgene to $67 - United Therapeutics (NASDAQ:UTHR)

ISI modified its price target on Celgene (NASDAQ:

) to $67. At the same time, the rating agency left its price target on United Therapeutics (NASDAQ:

) unchanged at $65. On Friday, Celgene lost 1.1% of its value to finish the week at $59.30, while UTHR rose 1.07% to end the day at $57.38.

To add Benzinga News as your preferred source on Google, click here.